日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Multimodal tumor-agnostic ctDNA analysis for minimal residual disease detection and risk stratification in ovarian cancer: results from the MITO16a/MaNGO-OV2 trial

多模式肿瘤非特异性ctDNA分析用于卵巢癌微小残留病灶检测和风险分层:MITO16a/MaNGO-OV2试验结果

Paracchini, L; Velle, A; Di Gennaro, P; Mannarino, L; Ancona, L; Lorusso, D; Cecere, S C; Colombo, N; Beltrame, L; Fagotti, A; Tasca, G; Piemontese, M; Arenare, L; Califano, D; Galdiero, F; Zadro, R; Chiodini, P; Perrone, F; Biagioli, E; D'Incalci, M; Romualdi, C; Pignata, S; Marchini, S

HR-SC-an academic-developed machine learning framework to classify HRD-positive ovarian cancer patients and predict sensitivity to olaparib

HR-SC 是一个学术界开发的机器学习框架,用于对 HRD 阳性卵巢癌患者进行分类并预测其对奥拉帕尼的敏感性。

Beltrame, L; Mannarino, L; Sergi, A; Velle, A; Treilleux, I; Pignata, S; Paracchini, L; Harter, P; Scambia, G; Perrone, F; González-Martin, A; Berger, R; Arenare, L; Hietanen, S; Califano, D; Derio, S; Van Gorp, T; Dalessandro, M L; Fujiwara, K; Provansal, M; Lorusso, D; Buderath, P; Masseroli, M; Ray-Coquard, I; Pujade-Lauraine, E; Romualdi, C; D'Incalci, M; Marchini, S

Homologous recombination repair status in advanced endometrial cancer: an exploratory biomarker analysis from the randomized, phase II MITOEND 3 trial

晚期子宫内膜癌同源重组修复状态:来自随机 II 期 MITOEND 3 试验的探索性生物标志物分析

Bartoletti, M; Passarelli, A; Fagotti, A; Andreetta, C; Tamberi, S; Lorusso, D; Pisano, C; Califano, D; Spina, A; De Angelis, C; Greco, F; De Cecio, R; Scaglione, G L; Russo, D; Ghizzoni, V; Cinieri, S; Sisoudiya, S D; Sokol, E S; Arenare, L; Schettino, C; Perrone, F; Farolfi, A; Pignata, S

Association of peripheral monocytic myeloid-derived suppressor cells with molecular subtypes in single-center endometrial cancer patients receiving carboplatin + paclitaxel/avelumab (MITO-END3 trial).

外周单核细胞髓系衍生抑制细胞与接受卡铂+紫杉醇/avelumab治疗的单中心子宫内膜癌患者的分子亚型的关联(MITO-END3试验)

D'Alterio C, Rea G, Napolitano M, Coppola E, Spina A, Russo D, Azzaro R, Mignogna C, Scognamiglio G, Califano D, Arenare L, Schettino C, Pisano C, Cecere S C, Di Napoli M, Passarelli A, Perrone F, Pignata S, Scala S

Alternative academic approaches for testing homologous recombination deficiency in ovarian cancer in the MITO16A/MaNGO-OV2 trial

MITO16A/MaNGO-OV2 试验中检测卵巢癌同源重组缺陷的替代学术方法

Capoluongo, E D; Pellegrino, B; Arenare, L; Califano, D; Scambia, G; Beltrame, L; Serra, V; Scaglione, G L; Spina, A; Cecere, S C; De Cecio, R; Normanno, N; Colombo, N; Lorusso, D; Russo, D; Nardelli, C; D'Incalci, M; Llop-Guevara, A; Pisano, C; Baldassarre, G; Mezzanzanica, D; Artioli, G; Setaro, M; Tasca, G; Roma, C; Campanini, N; Cinieri, S; Sergi, A; Musolino, A; Perrone, F; Chiodini, P; Marchini, S; Pignata, S

IFN-γ increases susceptibility to influenza A infection through suppression of group II innate lymphoid cells

IFN-γ通过抑制II型固有淋巴细胞增加对甲型流感病毒感染的易感性。

Califano, D; Furuya, Y; Roberts, S; Avram, D; McKenzie, A N J; Metzger, D W

Isolation of a SIR-like gene, SIR-T8, that is overexpressed in thyroid carcinoma cell lines and tissues

从甲状腺癌细胞系和组织中分离出一种过表达的SIR样基因SIR-T8

de Nigris, F; Cerutti, J; Morelli, C; Califano, D; Chiariotti, L; Viglietto, G; Santelli, G; Fusco, A

Thymosin beta-10 gene overexpression is a general event in human carcinogenesis

胸腺素β-10基因过表达是人类致癌过程中的普遍现象。

Santelli, G; Califano, D; Chiappetta, G; Vento, M T; Bartoli, P C; Zullo, F; Trapasso, F; Viglietto, G; Fusco, A

A potential pathogenetic mechanism for multiple endocrine neoplasia type 2 syndromes involves ret-induced impairment of terminal differentiation of neuroepithelial cells

多发性内分泌肿瘤2型综合征的潜在发病机制涉及RET诱导的神经上皮细胞终末分化障碍。

Califano, D; D'Alessio, A; Colucci-D'Amato, G L; De Vita, G; Monaco, C; Santelli, G; Di Fiore, P P; Vecchio, G; Fusco, A; Santoro, M; de Franciscis, V